Tevogen Bio Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	191	180	176	495	-
Market Cap Growth	-69.37%	2.42%	-64.45%	-	-
Enterprise Value	191	188	267	-	-
Last Close Price	1.01	1.03	11.13	10.33	-
PB Ratio	-	-27.02	-1.86	-14.58	-
Debt / Equity Ratio	-0.62	-0.43	-1.01	-1.18	-1.42
Quick Ratio	0.25	0.16	0.01	2.80	10.66
Current Ratio	0.35	0.26	0.02	2.98	10.74
Return on Assets (ROA)	-578.29%	-746.67%	-83.46%	-111.41%	-
Return on Capital (ROIC)	-	-	-156.85%	-131.49%	-
Earnings Yield	-16.60%	-7.61%	-34.36%	-4.45%	-
FCF Yield	-6.97%	-6.65%	-4.72%	-1.85%	-
Buyback Yield / Dilution	-424.97%	-492.57%	1.98%	-0.69%	-

Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q